REGISTERED
on 21 Mar 2023
Last Applicant/ Owned by
No.39, Keji Avenue, High-Tech Zone
Yantai, Shandong Prov.
CN
264670
Serial Number
97055156 filed on 30th Sep 2021
Registration Number
7003616 registered on 21st Mar 2023
Correspondent Address
Paulo A. de Almeida
Filing Basis
No Filing Basis
Disclaimer
NO DATA
BAHUMAB
Early evaluation of new drug implementation; Consulting services in the field of technology development; Research and development in the field of antibodies; Development of pharmaceutical preparations and medical drugs; Pharmaceutical drug development services; Biochemical research and analysis; Product development for others; Research and development of new products for others; Research and devel Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Early evaluation of new drug implementation; Consulting services in the field of technology development; Research and development in the field of antibodies; Development of pharmaceutical preparations and medical drugs; Pharmaceutical drug development services; Biochemical research and analysis; Product development for others; Research and development of new products for others; Research and development of new products; Pharmaceutical research services
Mark Details
Serial Number
No 97055156
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 21st Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 03rd Jan 2023 | PUBLISHED FOR OPPOSITION |
| 03rd Jan 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Dec 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th Nov 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 10th Nov 2022 | ASSIGNED TO LIE |
| 10th Nov 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 10th Nov 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 28th Sep 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |